Skip to main content
Annali di Stomatologia logoLink to Annali di Stomatologia
. 2014 May 9;5(2 Suppl):11.

Is bone scan (Tc99 scintigraphy) uptake predictive of clinical onset of osteonecrosis of jaw (ONJ)?

V Fusco 1, A Muni 1, H Rouhanifar 1, B Greco 1, L Tommasi 1
PMCID: PMC4377671

graphic file with name 1f7.jpg

Background

Data about early detection of ONJ by Bone Scan (99mTc-MDP scintigraphy) (BS) have been occasionally published1,2. Following data are in favour: a) BS is an imaging technique with high sensitivity; b) sporadic cases of early jawbone (maxilla or mandible) uptake have been reported, occasionally even months or years before clinical evidence of ONJ (bone exposure); c) the BS is performed periodically in patients with skeletal metastases to check out the status of disease activity and the response to specific treatments; consequently the research for early ONJ does not involve additional costs. Potential limitations include: a) maxilla or mandibular uptake could be due to metastatic lesions; b) BS is a technique with low specificity: beside neoplastic one, bone traumatic, inflammatory, degenerative lesions can determine an uptake; c) an undefined proportion of patients (even without any active tumor disease) shows jaw uptakes, due to dental diseases widely seen in the general population (abscesses, denture ulcers, periodontal disease, etc.); c) even in BP-related ONJ suspected cases, jaw uptake may be due to infections that are not necessarily connected to the osteomyelitis component of ONJ.

Methods

We conducted a retrospective study of routine BS performed in 12 ONJ patients treated with BPs (8 with breast cancer, 4 prostate cancer); BS was performed 6–12 months prior to definitive ONJ diagnosis. Two Nuclear Medicine specialists reviewed images.

Results

6–12 months prior to diagnosis, 8/12 BS were positive (evident jaw uptakes in ONJ sites), 3/12 were doubtful (moderate uptake) and 1 negative.

Conclusions

These preliminary data are interesting and challenging. A case-control study has been designed with different patient groups, including: ONJ cases; patients treated with BP and not suffering from ONJ; cancer patients not receiving BPs.

References

  • 1.O’Ryan Khoury S, Liao W, et al. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg. 2009 Jul;67(7):1363–72. doi: 10.1016/j.joms.2009.03.005. [DOI] [PubMed] [Google Scholar]
  • 2.Van den Wyngaert, Huizing MT, Fossion E, et al. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw. Clin Nucl Med. 2011 Jan;36(1):17–20. doi: 10.1097/RLU.0b013e3181feeb72. [DOI] [PubMed] [Google Scholar]

Articles from Annali di Stomatologia are provided here courtesy of CIC Edizioni Internazionali

RESOURCES